- Home
- PRME vs VCV Comparison
PRME vs VCV Comparison
Compare PRME & VCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | VCV |
|---|---|---|
| Founded | 2019 | N/A |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 543.1M |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PRME | VCV |
|---|---|---|
| Price | $3.34 | $11.20 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.42 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 104.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,983,000.00 | N/A |
| Revenue This Year | $95.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $9.51 |
| 52 Week High | $6.94 | $11.38 |
Technical Indicators
Market Signals| Indicator | PRME | VCV |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 53.70 |
| Support Level | $3.16 | $11.10 |
| Resistance Level | $3.39 | $11.32 |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 17.06 | 52.00 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.